Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

Neurology

Volumn 75, Issue 19, 2010, Pages 1711-1716

  Van Eimeren, T ^a,c   Pellecchia, G ^a,c   Cilia, R ^a,c   Ballanger, B ^a,c   Steeves, T D L ^b   Houle, S ^c   Miyasaki, J M ^b   Zurowski, M ^b   Lang, A E ^b   Strafella, A P ^a,b,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; LEVODOPA;

AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CASE CONTROL STUDY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRIVE; ELECTROENCEPHALOGRAM; GLOBUS PALLIDUS; HUMAN; IMPULSE CONTROL DISORDER; INHIBITION KINETICS; ORBITAL CORTEX; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROBABILITY;

EID: 78649506636     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fc27fa     Document Type: Article

References (16)

1. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
2. Bodi N, Keri S, Nagy H, et al. Reward-learning and the novelty-seeking personality: a between- and withinsubjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009;132:2385-2395.
3. van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 2009;34:2758-2766.
4. Baler RD, Volkow ND. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006;12:559-566.
5. Potenza MN. Review: the neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008;363:3181-3189.
6. Kim SW, Grant JE, Potenza MN, Blanco C, Hollander E. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res 2009;166:76-84.
7. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870-878.
8. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004; 47(suppl 1):3-13.
9. Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol 1995;363:615-641.
10. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 2001;4: 95-102.
11. Rolls ET. The orbitofrontal cortex and reward. Cereb Cortex 2000;10:284-294.
12. Klein TA, Neumann J, Reuter M, Hennig J, von Cramon DY, Ullsperger M. Genetically determined differences in learning from errors. Science 2007;318:1642-1645.
13. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 2004;24:11017-11022.
14. Grabli D, McCairn K, Hirsch EC, et al. Behavioural disorders induced by external globus pallidus dysfunction in primates: I: behavioural study. Brain 2004;127:2039-2054. (Pubitemid 39150262)
15. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001;158:2015-2021.
16. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132:1376-1385.